Issue 20, 2023

Semi-rational design of an imine reductase for asymmetric synthesis of alkylated S-4-azepanamines

Abstract

Although imine reductase (IRED)-catalyzed reductive amination is promising for the synthesis of alkylated chiral amines, precisely regulating the stereoselectivity of IRED remains a great challenge. Herein, focusing on the residues directly in contact with the ketone moiety, we applied structure-guided semi-rational design to obtain the triple-mutant I149Y/L200H/W234K. This mutant showed high stereoselectivity, of up to >99% (S), toward reductive amination of N-Boc-4-oxo-azepane and different amines, and to the best of our knowledge is the first biocatalyst developed for asymmetric synthesis of chiral azepane-4-amines.

Graphical abstract: Semi-rational design of an imine reductase for asymmetric synthesis of alkylated S-4-azepanamines

Supplementary files

Article information

Article type
Communication
Submitted
22 Mar 2023
Accepted
18 Apr 2023
First published
02 May 2023

Org. Biomol. Chem., 2023,21, 4181-4184

Semi-rational design of an imine reductase for asymmetric synthesis of alkylated S-4-azepanamines

F. Zhu, J. Zhang, Y. Ma, L. Yang, Q. Gao, S. Gao and C. Cui, Org. Biomol. Chem., 2023, 21, 4181 DOI: 10.1039/D3OB00442B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements